(IN BRIEF) Roche provided an update on its Phase III SKYSCRAPER-01 study, evaluating tiragolumab in combination with Tecentriq® for patients with PD-L1-high, advanced, or metastatic non-small cell lung cancer (NSCLC). The study did not meet its primary endpoint of improving … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Lung Cancer Therapy, Roche, safety, SKYSCRAPER-01 Study, TECENTRIQ, Tiragolumab
(IN BRIEF) Vodafone Business IoT and Controlant are transforming the pharmaceutical supply chain by providing real-time monitoring for temperature-sensitive medicines. Controlant’s Saga devices, equipped with Vodafone IoT SIMs, ensure reliable global connectivity, reducing waste and carbon emissions. This solution has … Read the full press release
Posted in Business, Environment, Financial, Government, Industrial, Internet & Online, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Controlant, Gísli Herjólfsson, partnership, Pharmaceutical Supply Chain, Real-time monitoring, sustainability, vodafone, Vodafone Business IoT
(IN BRIEF) Fresenius Kabi is addressing the global threat of antimicrobial resistance (AMR), which causes millions of deaths annually, through sustainable manufacturing, improved antibiotic access, and promoting responsible use. During AMR Awareness Week, the company highlighted its commitment to reducing … Read the full press release
(IN BRIEF) Research published in the European Heart Journal reveals that combining anticoagulants with NSAIDs, such as ibuprofen, diclofenac, or naproxen, significantly increases the risk of internal bleeding. The study, involving over 51,000 patients in Denmark, found that the bleeding … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Anticoagulants, diclofenac, Elevated Bleeding, ESC, Healthcare, ibuprofen, naproxen, NSAIDs, Professor Robert F. Storey, rivaroxaban, Søren Riis Petersen, warfarin
(IN BRIEF) AstraZeneca’s Tagrisso (osimertinib) has been recommended for approval in the EU for treating adult patients with unresectable, locally advanced non-small cell lung cancer (NSCLC) with EGFR mutations who have not experienced disease progression after platinum-based chemoradiation therapy. This … Read the full press release
Posted in Business, European Union, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Dr. Manuel Cobo, safety, Susan Galbraith, Tagrisso, therapy, Unresectable EGFR-Mutated Lung Cancer
(IN BRIEF) In his doctoral research at the University of Helsinki, Matej Zore demonstrated the potential of repurposing the drugs fingolimod and etrasimod, originally developed for autoimmune diseases, to combat antimicrobial resistance (AMR). These drugs showed notable efficacy against drug-resistant … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged antimicrobial resistance, etrasimod, fingolimod, Matej Zore, methicillin-resistant Staphylococcus aureus (MRSA), Professor Fredrik Almqvist, Professor Jari Yli-Kauhaluoma, Repurposing Drugs, University of Helsinki, vancomycin-resistant Enterococcus (VRE)
(IN BRIEF) Henkel and Linxens are collaborating to advance printed electronics for medical wearables, debuting a skin patch concept featuring self-regulating heating elements designed to enhance patient comfort. The innovation, ideal for applications like pain relief and temperature-regulated drug delivery, … Read the full press release
Posted in Chemicals, Germany, Healthcare, Pharma & Biotech
Tagged biosensors, carbon resistive inks, conductive inks, connectivity, flexible circuits, Healthcare, Henkel, INNOVATION, IoT, Linxens, Linxens Healthcare, Loctite portfolio, MEDICA trade show, medical wearables, Minh Lê, pain relief, patient comfort, Pia Schmiedel, Positive Temperature Coefficient inks, printed electronics, resistive inks, Roll-to-Roll screen printing, self-regulating heating elements, silver conductive inks, skin patches, temperature-controlled drug delivery
(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients with chronic rhinosinusitis with nasal polyps (CRSwNP), reducing both nasal polyp size and congestion compared to a placebo. The WAYPOINT trial … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, Amgen, AstraZeneca, chronic rhinosinusitis, Dr. Brian Lipworth, Dr. Joseph Han, Healthcare, Nasal Polyp Symptoms, partnership, safety, Sharon Barr, sustainability, tezepelumab, Tezspire, USA
(IN BRIEF) Logicor has extended its lease with DHL Poland at its Mysłowice logistics park, where DHL occupies 12,200 sqm of warehouse space and provides logistical support for Bausch Health Poland. The facility, tailored for pharmaceutical needs with advanced temperature … Read the full press release
Posted in Business, Environment, Financial, Government, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Poland, Real Estate, Technology, Transportation & Logistics, United Kingdom
Tagged DHL Poland, Logicor, Mysłowice, partnership, Pharmaceutical Logistics Hub, Piotr Brycki, sustainability
(IN BRIEF) The European Medicines Agency has approved Dupixent as the first treatment for eosinophilic esophagitis (EoE) in young children aged one to 11, marking a significant step in managing this condition in a critical developmental phase. The approval is … Read the full press release
Posted in Business, Education, European Union, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Dr. George Yancopoulos, Dr. Houman Ashrafian, Dupixent, eosinophilic esophagitis, EU, European Medicines Agency (EMA), Healthcare, Regeneron, safety, Sanofi, treatment, wellness, Young Children
(IN BRIEF) SGS has introduced advanced laser diffraction technology at its Wavre, Belgium lab, enhancing its ability to measure droplet sizes in spray drug delivery systems. This investment in Malvern Spraytec technology allows for real-time data collection during the spray … Read the full press release
Posted in Belgium, Business, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Belgium, investment, Laser Diffraction Technology, Malvern Spraytec laser diffraction system, partnership, Pharmaceutical Spray Testing, safety, SGS, sustainability
(IN BRIEF) Evotec SE has sold its chemical API-focused manufacturing site, Evotec DS GmbH, to Monacum Partners as part of its “Priority Reset” strategy to focus on core growth areas. The Halle/Westphalia-based facility, now renamed DAPIN GmbH, will continue its … Read the full press release
Posted in Business, Chemicals, Environment, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged acquisition, API Manufacturing Site, DAPIN GmbH, Evotec, Monacum Partners, partnership, sustainability
(IN BRIEF) QIAGEN’s QIAstat-Dx Meningitis/Encephalitis Panel has received FDA clearance, enabling faster and more accurate diagnosis of critical CNS infections like meningitis and encephalitis. This panel, the fourth QIAstat-Dx test approved in the U.S. in 2024, uses real-time PCR to … Read the full press release
(IN BRIEF) Accenture has invested in 1910 Genetics, a biotech firm leveraging AI-driven lab automation to enhance drug discovery for small and large molecule therapies. This partnership aims to provide biopharma clients with a powerful AI platform, streamlining the drug … Read the full press release
Posted in Artificial Intelligence (AI), Business, Environment, Financial, Government, Healthcare, Industrial, Ireland, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged 1910 Genetics, Accenture, AI-Driven Solutions, Dr. Cecil Lynch, Dr. Jen Nwankwo, Dr. Kailash Swarna, drug discovery, partnership, Petra Jantzer, sustainability, Tom Lounibos, USA
(IN BRIEF) Roche announced the publication of pivotal phase III results for its Itovebi™ (inavolisib)-based regimen at the Clinical Trials in Alzheimer’s Disease congress, demonstrating a 57% reduction in the risk of disease progression or death in patients with HR-positive, … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Dr. Komal Jhaveri, Healthcare, HR-Positive Breast Cancer, Itovebi, Levi Garraway, PIK3CA mutation, Roche, safety, Survival Benefits, wellness
(IN BRIEF) At the CTAD 2024 congress in Madrid, Roche presented new data on its Elecsys® Amyloid Plasma Panel and Elecsys ptau181, demonstrating their effectiveness in diagnosing Alzheimer’s disease. The blood-based test showed a negative predictive value of 96.2% in … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Media, News, Pharma & Biotech, Science, Spain, Switzerland, Technology
Tagged Alzheimer, Clinical Trials in Alzheimer’s Disease congress (CTAD) 2024, diagnostics, Elecsys ptau181, Elecsys® Amyloid Plasma Panel, Healthcare, Matt Sause, Roche, Spain
(IN BRIEF) QIAGEN has announced FDA clearance for its QIAstat-Dx Respiratory Panel Mini, marking the third such approval for the QIAstat-Dx system in 2024. Tailored for outpatient settings, this panel quickly detects five common respiratory pathogens—including influenza strains and SARS-CoV-2—enabling … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged FDA approval, influenza strains, Nadia Aelbrecht, Outpatient Respiratory Diagnostics, QIAGEN, QIAstat-Dx Mini Panel, Rapid Results, safety, SARS-CoV-2
(IN BRIEF) AstraZeneca’s Fasenra (benralizumab) has been approved in the European Union as an add-on treatment for adults with eosinophilic granulomatosis with polyangiitis (EGPA), a rare and severe form of vasculitis. The approval follows positive results from the MANDARA Phase … Read the full press release
Posted in Business, European Union, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AstraZeneca, Bernhard Hellmich, Eosinophilic Granulomatosis with Polyangiitis (EGPA), EU, Fasenra, patients, Rare Vasculitis, Ruud Dobber, safety
(IN BRIEF) AstraZeneca and Ionis’ drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating hereditary transthyretin-mediated amyloidosis (ATTRv-PN) in adults with stage 1 or 2 polyneuropathy. Based on the positive results from the NEURO-TTRansform Phase … Read the full press release
Posted in Business, European Union, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Dr. Laura Obici, EU, Hereditary Amyloidosis (ATTRv-PN), Ionis Pharmaceuticals, safety, Wainzua
(IN BRIEF) GSK and the University of Cambridge have announced a £50 million, five-year collaboration called the Cambridge-GSK Translational Immunology Collaboration (CG-TIC) to accelerate research and development in kidney and respiratory diseases. The initiative combines GSK’s expertise in immunology and … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AI, Cambridge University, Cambridge-GSK Translational Immunology Collaboration (CG-TIC), GSK, immunology, investment, Kidney and Respiratory Diseases, Nicolas Wisniacki, partnership, Peter Kyle, Professor David Thomas, safety, sustainability, Tony Wood
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?